Yahoo · Oct 29, 2026
Medpace Holdings, Inc. (MEDP) Hits Fresh High: Is There Still Room to Run?
Medpace (MEDP) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
HQ
NASDAQ · HQY
HealthEquity, Inc.
Healthcare · Medical - Healthcare Information Services
$102.03
Up+$5.27 (+5.16%)
Updated Nov 4, 2026, 6:58 PM
SID Score
4.9/10
Composite research score
Smart Money
58/100
Neutral
- Market cap
- 8.42B
- P/E ratio
- 43.63
- Dividend yield
- 0.00%
- 52-week range
- $72.76 – $107.62
- Volume
- 943.47K
- Avg. volume
- 875.23K
Price performance · HQY
HQY price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 3, 2026
HQY closed at $102.03 after 21 trading sessions, up 12.06% for the selected period.
- Last close
- $102.03
- Period change
- +12.06%
- Period low
- $89.87
- Period high
- $103.97
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 3, 2026 | $103.51 | $104.21 | $100.829 | $102.03 | 943.47K |
| Nov 2, 2026 | $102.85 | $105.21 | $102.35 | $103.67 | 991.25K |
| Oct 30, 2026 | $101.86 | $103.00 | $100.90 | $102.47 | 717.22K |
| Oct 29, 2026 | $102.28 | $103.45 | $101.255 | $101.36 | 596.64K |
| Oct 28, 2026 | $100.87 | $103.35 | $100.55 | $101.34 | 633K |
| Oct 27, 2026 | $103.13 | $104.1968 | $100.74 | $100.88 | 673.53K |
| Oct 26, 2026 | $104.05 | $105.55 | $102.89 | $103.75 | 909.46K |
| Oct 23, 2026 | $100.98 | $104.30 | $100.1905 | $103.97 | 1.02M |
| Oct 22, 2026 | $98.35 | $101.09 | $97.655 | $100.97 | 1.25M |
| Oct 21, 2026 | $96.72 | $98.86 | $96.25 | $97.88 | 725.8K |
| Oct 20, 2026 | $93.60 | $96.75 | $93.60 | $96.60 | 560.28K |
| Oct 19, 2026 | $91.53 | $93.24 | $90.91 | $93.07 | 532.93K |
| Oct 16, 2026 | $93.23 | $93.835 | $91.625 | $92.03 | 550.7K |
| Oct 15, 2026 | $90.75 | $92.90 | $89.79 | $92.51 | 735.48K |
| Oct 14, 2026 | $89.84 | $92.72 | $89.08 | $89.87 | 820.36K |
| Oct 13, 2026 | $92.43 | $92.725 | $89.92 | $90.19 | 858.15K |
| Oct 12, 2026 | $91.94 | $92.90 | $91.37 | $92.03 | 610.86K |
| Oct 9, 2026 | $92.98 | $93.96 | $92.02 | $92.61 | 555.91K |
| Oct 8, 2026 | $91.09 | $93.54 | $90.88 | $93.05 | 772.77K |
| Oct 7, 2026 | $91.05 | $92.98 | $91.00 | $91.90 | 893.04K |
| Oct 6, 2026 | $91.43 | $92.01 | $90.34 | $91.05 | 726.86K |
Latest HQY news
The latest Smart Investors Daily articles mentioning HQY.
Stock researchCompany · Overview
Company
Market Activity
Research & News
HQY research
Overview
Company profile and research snapshot.
Company profile
HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. It provides payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice to grow their tax-advantaged healthcare savings. It manages consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and administers Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It also provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $120.50
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Oct 21, 2026 | BMO Capital | Outperform | — |
| Sep 18, 2026 | Barclays | Overweight | — |
| Aug 31, 2026 | Deutsche Bank | Buy | — |
| Aug 28, 2026 | BTIG | Buy | — |
| Jul 24, 2026 | BTIG | Buy | — |
News briefing
No generated briefing is available yet.
Yahoo · Oct 28, 2026
Is HealthEquity (HQY) a Solid Growth Stock? 3 Reasons to Think "Yes"
HealthEquity (HQY) possesses solid growth attributes, which could help it handily outperform the market.
Benzinga · Oct 21, 2026
BMO Capital Maintains Outperform on HealthEquity, Raises Price Target to $125
BMO Capital analyst Sean Dodge maintains HealthEquity (NASDAQ:HQY) with a Outperform and raises the price target from $105 to $125.
SeekingAlpha · Oct 2, 2026
HealthEquity: AI Cash Fears Create A 'Buy' Opportunity
HealthEquity stock remains a "Buy" given its durable HSA growth, margin gains, and buybacks. Here's what investors need to know about HQY.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
